Thirupaimruth Raman
Pulmonary Disease · Springfield, MANPI 1801834395
Payments from drug & device makers
Across 207 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$851
- Sanofi-aventis U.S. LLC$391
- GSK$319
- Amgen$224
- E.r. Squibb & Sons, L.L.C.$220
- AstraZeneca$212
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,724100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $851 |
| Sanofi-aventis U.S. LLC | 16 | $391 |
| GSK | 20 | $319 |
| Amgen | 13 | $224 |
| E.r. Squibb & Sons, L.L.C. | 11 | $220 |
| AstraZeneca | 12 | $212 |
| Nestle Healthcare Nutrition Inc. | 8 | $170 |
| Grifols USA, LLC | 3 | $160 |
| Lilly USA, LLC | 6 | $151 |
| Boehringer Ingelheim | 7 | $150 |
| Merck | 7 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $104 |
| Johnson & Johnson | 6 | $100 |
| Amarin Pharma, Inc. | 5 | $87 |
| Novo Nordisk | 4 | $63 |
| Pfizer | 3 | $60 |
| Novartis | 3 | $59 |
| Mallinckrodt Enterprises LLC | 3 | $57 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| Phadia US Inc. | 2 | $42 |
| Sanofi | 2 | $38 |
| Abbott | 2 | $31 |
| Eisai Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C$125
- PRALUENT$105
How this compares
$3,724 in reported general payments places this provider in the 70th percentile of 482 pulmonary disease providers in Massachusetts.
Other pulmonary disease in Springfield
- Mary Jo FarmerSpringfield$131K
- Victor Pinto-PlataSpringfield$59K
- Aaron WaxmanBoston$7.7M
- John BerkBoston$6M
- Darrell KottonBoston$5.3M
- Hilary GoldbergBoston$3.5M
- Ehab BillatosWinchester$2.7M
- Harrison FarberBoston$2.6M
- Elizabeth KlingsBoston$2.1M
- Curtis MelloNorth Dartmouth$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.